Phoenix Biotech (PBAX) to Combine with Intrinsic Medicine in $207M Deal
Warning: DOMDocument::loadHTML(): Unexpected end tag : p in Entity, line: 5 in /var/convesio/wordpress/wp-content/plugins/spacinsider-upqode/src/Start.php on line 90
Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX) has entered into a definitive agreement to combine with preclinical-stage therapeutics company Intrinsic Medicine, Inc. at an enterprise value of $207.3 million. The Seattle, Washington-based company is a preclinical-stage therapeutics firm leveraging synthetic biology-manufactured human milk oligosaccharides (HMOs) to help treat gut-brain axis disorders (GBA). The combined company is expected
Read More